SOURCE: GenVault Corporation

December 19, 2006 09:00 ET

GenVault Awarded Key Biosample Management Patent

CARLSBAD, CA -- (MARKET WIRE) -- December 19, 2006 -- GenVault Corporation today announced the US Patent Office has issued US patent #7,142,987 giving GenVault broad rights to dry-state sample archiving, using carriers designed to store dried biosamples as discrete, individually addressable aliquots in a predetermined spatial relationship. This patent allows GenVault broad coverage to exclusively develop and market consumables for dry-state biosample storage, based on individual sample aliquots that are stored, one each, in a container which is in turn assembled in an orderly way with other sample containers to form an assembly. For instance this includes samples stored dry as racks of tubes, or samples stored dry in a 96 or 384 well plate format. The patent also covers the generalized use of hardware for organizing the storage of such dry-state sample aliquots to form sample archives. Finally, the patent covers the generalized use of software to track the location, use history and the data associated with such individually addressable dry-state samples, in the context of organized sample management and archiving.

This newly issued patent adds to GenVault's core IP for GenPlate® storage technology -- a multi-well plate system for room temperature, dry-state storage of DNA that eliminates the need for cryostorage.

"GenVault is continually strengthening its patent portfolio as a key strategy for growth and value," said David Wellis, GenVault's CEO. "Part of that strategy is to consolidate GenVault's position such that it enables the company to exclusively market consumable, hardware and software solutions that enable efficient biosample management and accessibility."

GenVault is a privately held company founded in 2001 and is funded by Domain Associates.

About GenVault

GenVault is the leader in providing DNA sample accessibility for genomic discovery, medicine and identification. GenVault serves customers across medical centers, academic institutions, pharmaceutical companies, and law enforcement agencies. As a scalable and reliable alternative to traditional freezer networks and DNA purification systems, GenVault's dry-state platform enables the extraction, preservation, recovery and distribution of DNA at room temperature. Future systems will also accommodate proteins and RNA to provide a comprehensive solution. From its GenPlate to its Dynamic Archive solution, GenVault is continuously developing and refining best practices for DNA sample management. For more information visit us at

GenPlate® is a registered US trademark of GenVault Corporation.

Contact Information


    Kerri McWeeny
    (760) 268-5257
    Email Contact

    Agency Contact:
    Doug Forsyth
    Alchymia Communications® LLC
    (541) 482-8744
    Email Contact